Hydroxychloroquine plus azithromycin treatment in elderly patients

被引：0
|
作者：
Gautret, Philippe [1 ,2 ]
Ly, Tran Duc Anh [1 ,2 ]
Raoult, Didier [1 ,3 ]
机构：
[1] IHU Mediterranee Infect, Marseille, France
[2] Aix Marseille Univ, IRD, AP HM, SSA,VITROME, Marseille, France
[3] Aix Marseille Univ, IRD, APHM, MEPHI, Marseille, France
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2021年 / 57卷 / 04期
关键词：
D O I：
10.1016/j.ijantimicag.2021.106313
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Timing and dosage may be the key in the realisation of hydroxychloroquine plus azithromycin treatment benefit in Covid-19 elderly patients
    Lacout, Alexis
    Lounnas, Valere
    Perronne, Christian
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2021, 57 (04)
  • [2] QT interval prolongation with hydroxychloroquine plus azithromycin
    Reactions Weekly, 2020, 1808 (1) : 12 - 12
  • [3] The Cardiovascular Effects of Treatment with Hydroxychloroquine and Azithromycin
    Simmering, Jacob E.
    Polgreen, Linnea A.
    Polgreen, Philip M.
    Teske, Rebecca E.
    Comellas, Alejandro P.
    Carter, Barry L.
    PHARMACOTHERAPY, 2020, 40 (09): : 978 - 983
  • [4] Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19
    Arshad, Samia
    Kilgore, Paul
    Chaudhry, Zohra S.
    Jacobsen, Gordon
    Wang, Dee Dee
    Huitsing, Kylie
    Brar, Indira
    Alangaden, George J.
    Ramesh, Mayur S.
    McKinnon, John E.
    O'Neill, William
    Zervos, Marcus
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 97 : 396 - 403
  • [5] Hydroxychloroquine and azithromycin as a treatment of COVID-19
    Alice Fanin
    Jessica Calegari
    Anna Beverina
    Silvia Tiraboschi
    Internal and Emergency Medicine, 2020, 15 : 841 - 843
  • [6] Hydroxychloroquine and azithromycin as a treatment of COVID-19
    Fanin, Alice
    Calegari, Jessica
    Beverina, Anna
    Tiraboschi, Silvia
    INTERNAL AND EMERGENCY MEDICINE, 2020, 15 (05) : 841 - 843
  • [7] Safety of Chloroquine or Hydroxychloroquine Plus Azithromycin for the Treatment of COVID-19 Patients in Burkina Faso: An Observational Prospective Cohort Study
    Rouamba, Toussaint
    Barry, Houreratou
    Ouedraogo, Esperance
    Tahita, Marc Christian
    Yameogo, Nobila Valentin
    Poda, Armel
    Diendere, Arnaud Eric
    Ouedraogo, Abdoul-Salam
    Valea, Innocent
    Kone, Amariane M.
    Thiombiano, Cherileila
    Traore, Isidore
    Tarnagda, Zekiba
    Sawadogo, Serge A.
    Gansane, Zakaria
    Kambire, Yibar
    Sanou, Idrissa
    Barro-Traore, Fatou
    Drabo, Maxime K.
    Tinto, Halidou
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2021, 17 : 1187 - 1198
  • [8] Combination of Hydroxychloroquine Plus Azithromycin As Potential Treatment for COVID-19 Patients: Safety Profile, Drug Interactions, and Management of Toxicity
    Hache, Guillaume
    Rolain, Jean Marc
    Gautret, Philippe
    Deharo, Jean-Claude
    Brouqui, Philippe
    Raoult, Didier
    Honore, Stephane
    MICROBIAL DRUG RESISTANCE, 2021, 27 (03) : 281 - 290
  • [9] Safety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients
    Gautret, Philippe
    Honore, Stephane
    Lagier, Jean-Christophe
    Raoult, Didier
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2021, 57 (01)
  • [10] Problems with the analysis in "Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19"
    Atkinson, J. Graham
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 99 : 37 - 37
12345